Blackstone Life Sciences Overview
- Investor Type
-
Private Equity
- Status
-
Active
- Professionals
-
22
- Investments
-
15
- Portfolio
-
10
- Exits
-
3
Blackstone Life Sciences General Information
Company Description
Founded in 2005 (Clarus Inception), Blackstone Life Sciences is a private equity investment strategy based in Cambridge, Massachusetts. The firm focuses on financing products in late-stage clinical development owned by life sciences companies, including pharmaceutical corporate collaborations, pre-approval royalties, and other opportunistic life sciences investments.
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- 314 Main Street
- 15th Floor
- Cambridge, MA 02142
- United States
Blackstone Life Sciences Investments (15)
Blackstone Life Sciences’s most recent investment was a with AvenCell for . The deal was made on 18-Oct-2024 with as the lead partner.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| AvenCell | 18-Oct-2024 | Biotechnology | Clinical Trials - Phase 2 | |||
| Moderna | 15-Mar-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
| Uniquity Bio | 19-Jan-2024 | Drug Discovery | Generating Revenue | |||
| Pfizer (Pharmaceuticals) | 20-Dec-2023 | Pharmaceuticals | Profitable | |||
| Sutro Biopharma | 21-Jun-2023 | PIPE | Drug Delivery | Generating Revenue/Not Profitable |
Blackstone Life Sciences Exits (3)
Blackstone Life Sciences has made a total of 3 exits. Its latest exit was from Reata Pharmaceuticals for on 26-Sep-2023. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Reata Pharmaceuticals | 26-Sep-2023 | ||
| Pearl Therapeutics | 27-Jun-2013 | Merger/Acquisition |
Blackstone Life Sciences Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Blackstone Life Sciences Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Blackstone Life Sciences FAQs
-
What is Blackstone Life Sciences?
Founded in 2005 (Clarus Inception), Blackstone Life Sciences is a private equity investment strategy based in Cambridge, Massachusetts.
-
When was Blackstone Life Sciences founded?
Blackstone Life Sciences was founded in 2005.
-
Where is Blackstone Life Sciences headquartered?
Blackstone Life Sciences is headquartered in Cambridge, MA.
-
What is Blackstone Life Sciences's total asset value?
Blackstone Life Sciences has around in total assets under management.
-
How many investments has Blackstone Life Sciences made?
Blackstone Life Sciences has made 15 investments.
-
What has Blackstone Life Sciences invested in?
Blackstone Life Sciences has made numerous investments in companies like AvenCell, Moderna, and Uniquity Bio within the Biotechnology and Drug Discovery industries.
-
What has Blackstone Life Sciences invested in recently?
Blackstone Life Sciences's latest investment was on 18-Oct-2024 in AvenCell, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
